Day One Biopharmaceuticals, Inc.
DAWNDelisted Apr 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Day One Biopharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 139 | 148 | +9 |
| Shares | 76.6M | 72.8M | −3.77M (−4.9%) |
| Value | $1.12B | $1.20B | +$84.5M (+7.6%) |
New holders (26)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (17)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Baker Bros. Advisors LP | 1,000,000 | $14.6M |
| Alyeska Investment Group, L.P. | 390,167 | $5.70M |
| Pier Capital, LLC | 258,685 | $3.78M |
| Point72 Asset Management, L.P. | 88,000 | $1.28M |
| HRT Financial LP | 73,887 | $1.08M |
| SG Americas Securities, LLC | 64,692 | $945.0K |
| Prelude Capital Management, LLC | 42,500 | $620.5K |
| Jupiter Asset Management Ltd | 36,671 | $535.4K |
| Gsa Capital Partners LLP | 30,378 | $444.0K |
| Cetera Advisor Networks LLC | 24,946 | $364.2K |
| Squarepoint Ops LLC | 15,927 | $232.5K |
| Vontobel Holding Ltd. | 15,500 | $226.3K |
| Cubist Systematic Strategies, LLC | 14,395 | $210.2K |
| E Fund Management Co., Ltd. | 12,618 | $184.2K |
| Dynamic Technology Lab Private Ltd | 10,651 | $156.0K |
| Sandia Investment Management LP | 5,980 | $87.3K |
| The PNC Financial Services Group, Inc. | 61 | $891 |